What is Cryofab?
Cryofab, Inc. operates as a premier manufacturer of specialized cryogenic storage and transfer equipment, serving a global client base that demands precision and reliability. The company maintains a comprehensive portfolio, ranging from standard dewars and transfer lines to bespoke cryogenic systems engineered for complex industrial applications. By leveraging over five decades of technical expertise, Cryofab has established itself as a critical supplier in the liquid gas supply chain, providing essential hardware that supports scientific research, energy distribution, and aerospace exploration. Their commitment to innovative design and rigorous manufacturing standards ensures that they remain a preferred partner for organizations requiring high-performance thermal management solutions.
How much funding has Cryofab raised?
Cryofab has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Cryofab
PPP
Public-Private Partnership
What's next for Cryofab?
With this latest round of financing, Cryofab is well-positioned to accelerate its long-term growth trajectory within the global industrial equipment marketplace. The strategic allocation of these funds is expected to focus on enhancing manufacturing throughput and expanding the company's footprint in emerging energy markets. As the demand for advanced cryogenic storage solutions continues to rise, particularly in the context of sustainable energy and space exploration, Cryofab is poised to leverage its deep industry experience to capture additional market share. The company's focus remains on maintaining its reputation for quality while scaling its operations to meet the evolving requirements of its diverse, international clientele.
See full Cryofab company page
